Why So Many Women Feel "Off" During Perimenopause — Even When Their Labs Look Normal
You wake up exhausted after a full night of sleep. You walk into a room and forget why you're there. If your labs look "normal" but nothing about how you feel does, perimenopause may be the missing piece nobody's mentioned yet.
Last updated: May, 2026
Something shifts in your 40s. You wake up exhausted after a full night of sleep. You walk into a room and forget why you came. You feel anxious in situations that never used to bother you, or find yourself irritable in a way that feels foreign to your own personality. Your period is still coming — maybe even regularly — and when you finally mention these symptoms to a physician, you're told your labs look fine.
And yet, nothing feels fine.
This experience is so common among women in their 40s that it has its own name: perimenopause. But despite how many women go through it, perimenopause remains one of the most under-recognized and under-treated phases of women's health. National Women's Health Week, with its 2026 theme of "Prevention, Innovation, and Impact: A New Era in Women's Health," is an appropriate moment to talk plainly about why so many women are told they're normal when they feel anything but, and what it means to receive care that actually accounts for what's happening in their bodies.
What Perimenopause Actually Is
Perimenopause is the hormonal transition that precedes menopause, which is officially defined as 12 consecutive months without a period. But perimenopause itself can begin years, sometimes a decade, before that point. Hormonal fluctuations during this transition can be profound — and unpredictable.
During perimenopause, estrogen does not decline in a steady, gradual arc. It swings. Some cycles produce surges of estrogen that are higher than what you experienced in your 30s. Others dip sharply. Progesterone, which is produced after ovulation, tends to decline more consistently as ovulation becomes irregular. The result is a hormonal environment that is erratic by design — and the body's response to that instability can affect nearly every system.
What makes this particularly complicated is that standard lab panels — FSH and estradiol, typically — are often measured at a single point in time. When estrogen is cycling unpredictably, a single measurement can appear completely normal even when the pattern over the course of a month tells a very different story. A normal FSH at one point in your cycle does not mean your hormonal environment is stable. It means that on the day your blood was drawn, one marker fell within a reference range.
Symptoms That Go Unexplained — And Why
The disconnect between lab results and lived experience is not a mystery once you understand the scope of hormonal influence. Estrogen, progesterone, and testosterone receptors exist throughout the brain, the cardiovascular system, the gut, and the musculoskeletal system. When those hormones fluctuate unpredictably, symptoms are wide-ranging.
Here is a partial picture of what perimenopause can look like before a single lab value confirms it:
Sleep disruption. Progesterone has a calming, sleep-promoting effect. As it declines, many women find they wake at 2 or 3 in the morning and cannot fall back asleep, even without the night sweats people typically associate with menopause.
Brain fog and difficulty concentrating. Estrogen plays a role in cognitive function and the regulation of acetylcholine, a neurotransmitter involved in memory. Fluctuations can produce a cognitive "static" that is real, neurologically grounded, and still frequently dismissed.
Mood changes, anxiety, and irritability. Estrogen modulates serotonin and GABA, both of which regulate mood. Women with no prior history of anxiety sometimes develop it for the first time in perimenopause. The same is true of low-grade depression.
Fatigue that sleep does not fix. When cortisol rhythms are disrupted by poor sleep, and thyroid function shifts slightly in response to hormonal changes, the resulting fatigue can feel like a wall that no amount of rest addresses.
Weight changes, particularly around the midsection. Estrogen influences where fat is stored. As levels shift, fat distribution tends to migrate centrally — a change that is also metabolically significant and connected to insulin sensitivity.
Joint pain. Estrogen has anti-inflammatory properties. Its decline is associated with increased musculoskeletal discomfort, which many women are surprised to learn may be hormonal in origin.
Research published in the journal Menopause found that women report a significantly higher symptom burden during the perimenopause transition than in either the late reproductive years or post-menopause, underscoring that this is often the most symptomatic period of the entire transition. (The Menopause Society, formerly NAMS, tracks this literature extensively through its clinical practice resources.)
Why "Your Labs Are Normal" Is Not the Full Answer
Standard lab panels were not designed to capture the complexity of perimenopause. Reference ranges for estradiol and FSH reflect population averages — they do not reflect your baseline, your symptom experience, or the pattern of your individual hormonal fluctuation across a cycle.
Beyond that, the evaluation of perimenopause symptoms requires clinical judgment that extends beyond a single blood draw. A thorough assessment includes:
A detailed menstrual history, including changes in cycle length, flow, and pattern
Sleep quality and continuity, not just hours slept
Cognitive changes, including word-finding, memory, and concentration
Mood shifts relative to the individual's baseline
Cardiovascular symptoms including palpitations, which are common and frequently unattributed to hormonal change
Metabolic markers including fasting insulin, glucose, and lipid patterns, which can shift meaningfully during the perimenopausal transition
This kind of evaluation takes time. It also requires a physician who understands the clinical presentation of perimenopause well enough to connect symptoms that appear unrelated — which is precisely why board certification in menopause medicine matters.
The Metabolic Layer Most Providers Miss
One of the least-discussed aspects of the perimenopausal transition is its metabolic impact. As estrogen shifts, insulin sensitivity frequently declines. Women who had no difficulty maintaining their weight in their 30s begin to notice that the same habits produce different results. Visceral fat accumulation increases cardiovascular and metabolic risk in ways that extend well beyond aesthetics.
This is where the intersection of menopause medicine and obesity medicine becomes clinically meaningful. Weight changes during perimenopause are not primarily a lifestyle failure. They are a metabolic response to a changing hormonal environment — and addressing them requires understanding both the hormonal and metabolic mechanisms at work.
For women who are also navigating insulin resistance, prediabetes, or concerns about cardiovascular risk, the perimenopausal window is a critical intervention point. Research increasingly supports that the years just before and immediately after menopause represent a window of cardiovascular and metabolic vulnerability that responds well to proactive management.
According to the American Heart Association, cardiovascular disease risk in women accelerates after menopause, and the perimenopausal transition itself is associated with adverse changes in lipid profiles, blood pressure, and body composition. The case for early, preventive intervention is not speculative. It is evidence-based.
What Care That Actually Helps Looks Like
Women navigating perimenopause deserve more than reassurance that their numbers are normal. They deserve a physician who has the training to interpret their symptoms in full clinical context, the time to take a complete history, and the expertise to build a care plan that accounts for where they are in the hormonal transition — not just a reference range.
Concierge medicine, by design, allows for the kind of extended appointments and continuity of care that perimenopause evaluation requires. A 15-minute visit cannot address sleep, mood, cognition, metabolic markers, and menstrual history. A relationship-based practice model can.
At Asklia Concierge and Metabolic Medicine, Dr. Ariel Brooks brings dual board certification in Obesity Medicine (ABOM) and recognition as a Menopause Society Certified Practitioner (MSCP) to every patient encounter. That combination is not incidental. It reflects a clinical understanding that the hormonal and metabolic changes of perimenopause are deeply interconnected, and that treating one without addressing the other produces incomplete outcomes. Patients at Asklia receive the time, the clinical depth, and the menopause-informed perspective that so many women have not found elsewhere.
Perimenopause Is a Medical Event, Not a Phase to Wait Through
Women who feel "off" during perimenopause are not imagining it. They are experiencing the physiological consequences of a significant hormonal transition — one that affects the brain, the cardiovascular system, metabolism, sleep, and mood simultaneously.
Waiting for labs to confirm what your body is already telling you is not the only option. Neither is accepting that what you are experiencing falls outside the scope of what medicine can address.
The new era in women's health that National Women's Health Week describes is not a vision for the distant future. It is available now, in practices built around listening to women, taking their symptoms seriously, and offering the specialized care that perimenopause actually demands.
